Tumor-infiltrating lymphocytes and immune-related adverse events in advanced melanoma.
van Duin IAJ, Schuiveling M, Ter Maat LS, Veta M, van Eijs MJM, Verheijden RJ, van den Berkmortel FWPJ, Boers-Sonderen MJ, Hospers GAP, Labots M, de Groot JWB, Kapiteijn E, Piersma D, Vreugdenhil G, Westgeest H, Schrader AMR, van Diest PJ, Blokx WAM, Suijkerbuijk KPM.
van Duin IAJ, et al. Among authors: van den berkmortel fwpj.
Immunooncol Technol. 2024 Jun 12;24:100714. doi: 10.1016/j.iotech.2024.100714. eCollection 2024 Dec.
Immunooncol Technol. 2024.
PMID: 39045171
Free PMC article.